Scientists reveal new blood pressure treatment that works when others fail
SMRTR summary
Baxdrostat, a new blood pressure drug, lowered readings by 9-10 mmHg in treatment-resistant patients by blocking aldosterone hormone production. The medication helped 40% of patients achieve healthy blood pressure levels versus 20% with placebo.
SMRTR provides this summary for quick context. The original article belongs to Science Daily.
Read the original article